KATALIN WOLFORD

Allopathic & Osteopathic Physicians|Internal Medicine VANCOUVER, WA NPI 1306862834

General Payments — all program years on this page

$8,515.32

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 435
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $452.23 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $452.2314

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $176.563
Amgen Inc. $94.782
Novo Nordisk AS $63.673
E.R. Squibb & Sons, L.L.C. $24.181
Abbott Laboratories $24.031
Lilly USA, LLC $18.791
ABBVIE INC. $17.081
PFIZER INC. $17.011
Lundbeck LLC $16.131

By program year

Program yearAmountRecords
2018 $2,462.20137
2019 $1,142.3660
2020 $105.802
2021 $825.2846
2022 $1,988.13104
2023 $1,539.3272
2024 $452.2314

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096713353 Novo Nordisk Inc $19.07 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097239103 Novo Nordisk Inc $21.47 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097733549 Novo Nordisk Inc $23.13 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101434343 E.R. Squibb & Sons, L.L.C. $24.18 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105424030 AstraZeneca Pharmaceuticals LP $123.18 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105508020 AstraZeneca Pharmaceuticals LP $23.62 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105552356 AstraZeneca Pharmaceuticals LP $29.76 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106353919 ABBVIE INC. $17.08 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111741548 Amgen Inc. $17.02 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111741550 Amgen Inc. $77.76 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124978085 Abbott Laboratories $24.03 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131098536 PFIZER INC. $17.01 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135076455 Lilly USA, LLC $18.79 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145982285 Lundbeck LLC $16.13 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.